(Q33274875)

25 July 2017

Multidisciplinary management of recurrent chordomas (English)

1 reference

25 July 2017

0 references

2

Mrinal Gounder

1 reference

25 July 2017

Yoshiya Yamada

1

1 reference

PubMed ID

23860859

25 July 2017

Ilya Laufer

series ordinal

3

1 reference

25 July 2017

1 September 2013

1 reference

Current Treatment Options in Oncology

25 July 2017

1 reference

25 July 2017

14

1 reference

25 July 2017

3

1 reference

25 July 2017

442-453

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-013-0247-3

25 July 2017

0 references

cites work

Chordoma: incidence and survival patterns in the United States, 1973-1995.

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Primary bone tumors of the spine. Terminology and surgical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Chordoma of the mobile spine: fifty years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Operative management of sacral chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Surgical margins and local control in resection of sacral chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

The surgical management of sacral chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

En bloc resection of primary sacral tumors: classification of surgical approaches and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Clinical and pathologic review of 48 cases of chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Sacral chordoma: 40-year experience at a major cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

A molecular map of mesenchymal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Imatinib mesylate in chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Response to imatinib plus sirolimus in advanced chordoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Phase II study on lapatinib in advanced EGFR-positive chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0247-3

Tumor response to radiotherapy regulated by endothelial cell apoptosis

21 January 2018

1 reference

12 December 2020

De novo dedifferentiated chordoma of the sacrum: a case report and review of the literature.

1 reference

12 December 2020

Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases

1 reference

12 December 2020

Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma.

1 reference

12 December 2020

A system of staging musculoskeletal neoplasms

1 reference

12 December 2020

Chordoma: the results of megavoltage radiation therapy

1 reference

12 December 2020

10.1007/S11864-013-0247-3

Identifiers

DOI

1 reference

PubMed ID

23860859

Dimensions Publication ID

25 July 2017

0 references

1 reference

PubMed ID

23860859